Cell cycle, CDKs and cancer: a changing paradigm

Malumbres, Marcos, Barbacid, Mariano·2009·Nature Reviews Cancer

Cited by (1,005)

Items 801–900 of 1,005

  1. Active Ingredients from Chinese Medicine for Combination Cancer Therapy
    Xuan Wang, Jing Li, Ruie Chen, Ting Li, Meiwan Chen · 2023 · International Journal of Biological Sciences
  2. Genomic landscape of salivary gland tumors
    Shumei Kato, Sheryl Krevsky Elkin, Maria Clemence Schwaederle, Brett N. Tomson, Teresa L. Helsten, Jennifer L. Carter, Razelle Kurzrock · 2015 · Oncotarget
  3. IFI27, a novel epidermal growth factor‐stabilized protein, is functionally involved in proliferation and cell cycling of human epidermal keratinocytes
    W.‐L. Hsieh, Yu‐Huei Huang, T.‐M. Wang, Yung-Ching Ming, Chi‐Neu Tsai, Jong‐Hwei S. Pang · 2015 · Cell Proliferation
  4. Integrating transcriptomics and proteomics to show that tanshinone IIA suppresses cell growth by blocking glucose metabolism in gastric cancer cells
    Li‐Ling Lin, Chieh-Ren Hsia, Chia‐Lang Hsu, Hsuan‐Cheng Huang, Hsueh‐Fen Juan · 2015 · BMC Genomics
  5. βKlotho Suppresses Tumor Growth in Hepatocellular Carcinoma by Regulating Akt/GSK-3β/Cyclin D1 Signaling Pathway
    Xiaoming Ye, Yu Guo, Qi Zhang, Wenjie Chen, Xuefeng Hua, Wei Liu, Yang Yang, Guihua Chen · 2013 · PLoS ONE
  6. Regulation of p27 Kip1 by mitogen-induced tyrosine phosphorylation
    Heidelinde Jäkel, Ines Peschel, Clarissa Kunze, Christina Weinl, Ludger Hengst · 2012 · Cell Cycle
  7. ERRα metabolic nuclear receptor controls growth of colon cancer cells
    Gérald Bernatchez, Véronique Giroux, Thomas Lassalle, André C. Carpentier, Nathalie Rivard, Julie C. Carrier · 2013 · Carcinogenesis
  8. A primer for studying cell cycle dynamics of the human hair follicle
    Talveen S. Purba, Lars Brunken, Nathan J. Hawkshaw, Michael Peake, Jonathan Alan Hardman, Ralf Paus · 2016 · Experimental Dermatology
  9. Anti-cancer effect of toosendanin and its underlying mechanisms
    Sha Zhang, Liang Cao, Zongren Wang, Zhe Li, Jing Ma · 2018 · Journal of Asian Natural Products Research
  10. CDK8-Novel Therapeutic Opportunities
    Ingeborg Menzl, Agnieszka Witalisz‐Siepracka, Veronika Sexl · 2019 · Pharmaceuticals
  11. Increased glucocorticoid receptor activity and proliferation in metastatic colon cancer
    Dan Tian, Miao Tian, Gang Han, Jinlong Li · 2019 · Scientific Reports
  12. Computational assessment of MCM2 transcriptional expression and identification of the prognostic biomarker for human breast cancer
    Abdus Samad, Farhana Haque, Zulkar Nain, Rahat Alam, Md Abdullah Al Noman, Mohammad Habibur Rahman Molla, Md Saddam Hossen, Md Raquibul Islam, Md. Iqbal Khan, Foysal Ahammad · 2020 · Heliyon
  13. Apigenin inhibits the growth of colorectal cancer through down-regulation of E2F1/3 by miRNA-215-5p
    Yuan Cheng, Xuejiao Han, Fei Mo, Hao Zeng, Yunuo Zhao, Hang Wang, Yue Zheng, Xuelei Ma · 2021 · Phytomedicine
  14. Targeting Oncogenic Pathways in the Era of Personalized Oncology: A Systemic Analysis Reveals Highly Mutated Signaling Pathways in Cancer Patients and Potential Therapeutic Targets
    Alexandros Karagiannakos, Maria Adamaki, Antonis Tsintarakis, Bořivoj Vojtěšek, Robin Fåhræus, Vassilis C. Zoumpourlis, Konstantinos Karakostis · 2022 · Cancers
  15. An update on the implications of cyclin D1 in melanomas
    González‐Ruiz, Lucia, González‐Moles, Miguel Ángel, González‐Ruiz, Isabel, Ruiz‐Ávila, Isabel, Ayén, Ángela, Ramos‐García, Pablo · 2020 · Pigment Cell & Melanoma Research
  16. Menthol: An underestimated anticancer agent
    Yijia Zhao, Huafeng Pan, Wei Liu, E. Liu, Yaobin Pang, Hongjin Gao, Qingying He, Wenhao Liao, Yejing Yao, Jinhao Zeng et al. · 2023 · Frontiers in Pharmacology
  17. UHRF1 phosphorylation by cyclin A2/cyclin-dependent kinase 2 is required for zebrafish embryogenesis
    Jaime Chu, Elizabeth A. Loughlin, Naseem Akhtar Gaur, Sucharita SenBanerjee, Vinitha Jacob, Christopher Monson, Brandon Kent, Amanke C. Oranu, Yuanying Ding, Chinweike Ukomadu et al. · 2011 · Molecular Biology of the Cell
  18. Coordinating cell polarity and cell cycle progression: what can we learn from flies and worms?
    Anna Noatynska, Nicolas Tavernier, Monica Gotta, Lionel Pintard · 2013 · Open Biology
  19. MLL fusion-driven activation ofCDK6potentiates proliferation inMLL-rearranged infant ALL
    Marieke Van der Linden, Merel Willekes, Eddy H.J. Van Roon, Lidija Seslija, Pauline Schneider, Rob Pieters, Ronald W. Stam · 2014 · Cell Cycle
  20. Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 Inhibitors
    Young Shin Cho, Hayley C. Angove, Christopher T. Brain, Christine Hiu-Tung Chen, Hong Cheng, Robert Cheng, Rajiv Chopra, Kristy Chung, Miles Congreve, Claudio Dagostin et al. · 2012 · ACS Medicinal Chemistry Letters
  21. Coordination of cell growth and division by the ubiquitin–proteasome system
    Jennifer A. Benanti · 2012 · Seminars in Cell and Developmental Biology
  22. Concurrent Deletion of Cyclin E1 and Cyclin-Dependent Kinase 2 in Hepatocytes Inhibits DNA Replication and Liver Regeneration in Mice
    Wei Hu, Yulia Alexandrowna Nevzorova, Ute Haas, Nives Moro, Piotr Siciński, Yan Geng, Mariano Barbacid, Christian Trautwein, Christian Liedtke · 2013 · Hepatology
  23. miR‐142‐3p inhibits cancer cell proliferation by targeting CDC 25C
    Xuchen Cao, Yue Yu, Likun Hou, Sun Xiao-hu, Jie Ge, Bin Zhang, Xin Wang · 2016 · Cell Proliferation
  24. Cyclin-dependent Kinase-mediated Sox2 Phosphorylation Enhances the Ability of Sox2 to Establish the Pluripotent State
    Juan Ouyang, Wei Yu, Jing Liu, Nian Zhang, Laurence A. Florens, Jiekai Chen, He Liu, Michael P. Washburn, Duanqing Pei, Ting Xie · 2015 · Journal of Biological Chemistry
  25. Concordance of copy number loss and down-regulation of tumor suppressor genes: a pan-cancer study
    Min Zhao, Zhongming Zhao · 2016 · BMC Genomics
  26. NEAT1 promotes colon cancer progression through sponging miR‐495‐3p and activating CDK6 in vitro and in vivo
    Zhiyun He, Jie Dang, Ailin Song, Xiang Cui, Zhijun Ma, Zhongtao Zhang · 2019 · Journal of Cellular Physiology
  27. Novel cyclin-dependent kinase 9 (CDK9) inhibitor with suppression of cancer stemness activity against non-small-cell lung cancer
    Xin Wang, Chenhua Yu, Cheng Wang, Yakun Ma, Tianqi Wang, Yao Li, Zhi liang Huang, Manqian Zhou, Peiqing Sun, Jian‐Yu Zheng et al. · 2019 · European Journal of Medicinal Chemistry
  28. Silencing TTK expression inhibits the proliferation and progression of prostate cancer
    Saipeng Chen, Jianan Wang, Lin Wang, Huahong Peng, Longfei Xiao, Changying Li, Dong Lin, Kuo Yang · 2019 · Experimental Cell Research
  29. A kinase of many talents: non-neuronal functions of CDK5 in development and disease
    Samanta Sharma, Piotr Siciński · 2020 · Open Biology
  30. A divergent cyclin/cyclin-dependent kinase complex controls the atypical replication of a malaria parasite during gametogony and transmission
    Aurélia C. Balestra, Mohammad Zeeshan, Edward Rea, Carla Pasquarello, Lorenzo Brusini, Tobias Mourier, Amit Kumar Subudhi, Natacha Klages, Patrizia Arboit, Rajan Pandey et al. · 2020 · eLife
  31. Rapamycin inhibits BAFF-stimulated cell proliferation and survival by suppressing mTOR-mediated PP2A-Erk1/2 signaling pathway in normal and neoplastic B-lymphoid cells
    Qingyu Zeng, Hai Zhang, Jiamin Qin, Zhigang Xu, Lin Gui, Beibei Liu, Chunxiao Liu, Chong Xu, Wen Liu, Shuangquan Zhang et al. · 2015 · Cellular and Molecular Life Sciences
  32. Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery
    Javier Rodríguez‐Ubreva, Ariel Ernesto Cariaga-Martínez, M. Alicia Cortés, M Romero-De Pablos, Santiago Ropero, Pilar López‐Ruiz, Begoña Colás · 2009 · Oncogene
  33. Proteomic characterization of post-translational modifications in drug discovery
    Linhui Zhai, Kai‐Feng Chen, Bingbing Hao, Minjia Tan · 2022 · Acta Pharmacologica Sinica
  34. Knockdown of EHF inhibited the proliferation, invasion and tumorigenesis of ovarian cancer cells
    Zhongping Cheng, Jing Guo, Li Chen, Ning Luo, Weihong Yang, Xiaoyan Qu · 2015 · Molecular Carcinogenesis
  35. Whether to target single or multiple CDKs for therapy? That is the question
    Józefa Węsierska‐Gądek, Margarita Maurer‐Granofszky, Nora Zulehner, Oxana Komina · 2010 · Journal of Cellular Physiology
  36. microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma
    Naoko Kikkawa, Takashi Kinoshita, Nijiro Nohata, Toyoyuki Hanazawa, Noriko Yamamoto, ICHIRO FUKUMOTO, Takeshi Chiyomaru, Hideki Enokida, Masayuki Nakagawa, Yoshitaka Okamoto et al. · 2014 · International Journal of Oncology
  37. A Novel Series of Highly Potent 2,6,9-Trisubstituted Purine Cyclin-Dependent Kinase Inhibitors
    Tomáš Gucký, Radek Jorda, Marek Zatloukal, Václav Bazgier, Karel Berka, Eva Řezníčková, Tibor Béreš, Miroslav Strnad, Vladimı́r Kryštof · 2013 · Journal of Medicinal Chemistry
  38. Apigenin induces DNA damage through the PKCδ-dependent activation of ATM and H2AX causing down-regulation of genes involved in cell cycle control and DNA repair
    Daniel Arango, Arti Parihar, Frederick A. Villamena, Liwen Wang, Michael A. Freitas, Erich Grotewold A, Andrea I. Doseff · 2012 · Biochemical Pharmacology
  39. Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells
    Yoshinobu Odaka, Baoshan Xu, Yan Luo, Tao Shen, Chaowei Shang, Yang Wu, Hongyu Zhou, Shile Huang · 2013 · Carcinogenesis
  40. Molecular mechanisms underlying mangiferin-induced apoptosis and cell cycle arrest in A549 human lung carcinoma cells
    SHI, WEI, DENG, JIAGANG, TONG, RONGSHENG, YANG, YONG, HE, XIA, LV, JIANZHEN, WANG, HAILIAN, DENG, SHAOPING, QI, PING, ZHANG, DINGDING et al. · 2016 · Molecular Medicine Reports · Retracted
  41. Identification of RNA-Binding Protein LARP4B as a Tumor Suppressor in Glioma
    Hideto Koso, Hungtsung Yi, Paul J. Sheridan, Satoru Miyano, Yasushi Ino, Tomoki Todo, Sumiko Watanabe · 2016 · Cancer Research
  42. Palbociclib, a selective inhibitor of cyclin-dependent kinase4/6, blocks HIV-1 reverse transcription through the control of sterile α motif and HD domain-containing protein-1 (SAMHD1) activity
    Eduardo Pauls, Roger Badía, Javier Torres‐Torronteras, Alba Ruiz, Marc Permanyer, Eva Riveira‐Muñoz, Bonaventura Clotet, Ramón Martí, Ester Ballana, José A. Esté · 2014 · AIDS
  43. Inhibitory Effects of Metabolites of 5-Demethylnobiletin on Human Nonsmall Cell Lung Cancer Cells
    Mingyue Song, Noppawat Charoensinphon, Xian Wu, Jinkai Zheng, Zili Gao, Fei Xu, Minqi Wang, Hang Xiao · 2016 · Journal of Agricultural and Food Chemistry
  44. Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2
    Alexey Valeryevich Danilov, Shanhu Hu, Bernardo Orr, Kristina M. Godek, Lisa Maria Mustachio, David Sekula, Xi Liu, Masanori Kawakami, Faye M. Johnson, Duane A. Compton et al. · 2016 · Molecular Cancer Therapeutics
  45. Accurate Prediction of Complex Structure and Affinity for a Flexible Protein Receptor and Its Inhibitor.
    G. Bekker, N. Kamiya, M. Araki, I. Fukuda, Y. Okuno, Haruki Nakamura · 2017 · Journal of Chemical Theory and Computation
  46. Selenium-Containing Polysaccharide-Protein Complex in Se-Enriched Ulva fasciata Induces Mitochondria-Mediated Apoptosis in A549 Human Lung Cancer Cells
    Xian Liang Sun, Yu Zhong, Hongtian Luo, Yufeng Yang · 2017 · Marine Drugs
  47. Ginkgolic acid induces interplay between apoptosis and autophagy regulated by ROS generation in colon cancer
    Yuxia Liu, Bin Yang, Lirong Zhang, Xianling Cong, Zhen Liu, Yu Hu, Jing Zhang, Haixia Hu · 2018 · Biochemical and Biophysical Research Communications
  48. Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma
    Yuan Qiao, Jingtao Chen, Chao Ma, Yingmin Liu, Peitong Li, Yalin Wang, Lin Hou, Ziling Liu · 2018 · Cellular Physiology and Biochemistry
  49. Magnoflorine inhibits human gastric cancer progression by inducing autophagy, apoptosis and cell cycle arrest by JNK activation regulated by ROS
    Xiaoli Sun, Xinwu Zhang, Hongjun Zhai, Di Zhang, Shuangyu Ma · 2020 · Biomedicine & Pharmacotherapy
  50. Discovery of coumarin derivatives as potent and selective cyclin-dependent kinase 9 (CDK9) inhibitors with high antitumour activity
    Junyu Xu, Hongmei Li, Xinren Wang, Jianhang Huang, Shuwen Li, Chenhe Liu, Ruinan Dong, Gaoyuan Zhu, Chunqi Duan, Fei Jiang et al. · 2020 · European Journal of Medicinal Chemistry
  51. LINC00511 knockdown enhances paclitaxel cytotoxicity in breast cancer via regulating miR-29c/CDK6 axis
    Hualong Zhang, Bin Zhao, Xiuxia Wang, Fan Zhang, Wenlong Yu · 2019 · Life Sciences
  52. Morusin exerts anti-cancer activity in renal cell carcinoma by disturbing MAPK signaling pathways
    Chengfei Yang, Jing Luo, Xing Luo, Weisheng Jia, Zhenqiang Fang, Shanhong Yi, Longkun Li · 2020 · Annals of Translational Medicine
  53. Fluorinated benzylidene indanone exhibits antiproliferative activity through modulation of microtubule dynamics and antiangiogenic activity
    Ankita Srivastava, Kaneez Fatima, Eram Fatima, Arjun Singh, Aastha Singh, Aparna Shukla, Suaib Luqman, Karuna Shanker, Debabrata Chanda, Feroz Khan et al. · 2020 · European Journal of Pharmaceutical Sciences
  54. Bioinformatics Study of Sea Cucumber Peptides as Antibreast Cancer Through Inhibiting the Activity of Overexpressed Protein (EGFR, PI3K, AKT1, and CDK4)
    Teresa Liliana Wargasetia, Hana Ratnawati, Nashi Widodo, Muhammad Hermawan Widyananda · 2021 · Cancer Informatics
  55. Cyclin-Dependent Kinase 4 and 6 Inhibitors in Cell Cycle Dysregulation for Breast Cancer Treatment
    Ni Made Pitri Susanti, Daryono Hadi Tjahjono · 2021 · Molecules
  56. Natural quinazolinones: From a treasure house to promising anticancer leads
    Hanbing Li, Gaohang Fu, Weihui Zhong · 2022 · European Journal of Medicinal Chemistry
  57. Cell cycle machinery in oncology: A comprehensive review of therapeutic targets
    Simona Daniela Cavalu, Amir Mohamed Abdelhamid, Sameh Saber, Elsayed A. Elmorsy, Rabab S. Hamad, Mustafa Ahmed Abdel‐Reheim, Galal Yahya, Mohamed Magdy Salama · 2024 · The FASEB Journal
  58. Exploring the selectivity of a ligand complex with CDK2/CDK1: a molecular dynamics simulation approach
    Sunil Kumar Tripathi, Sanjeev Kumar Singh, Poonam C. Singh, Chella Perumal Palanisamy, Karnati Konda Reddy, Chandrabose Selvaraj · 2012 · Journal of Molecular Recognition
  59. Cyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristics
    Shumei Kato, Maria Clemence Schwaederle, Gregory A. Daniels, David Eric Piccioni, Santosh Kesari, Lyudmila A. Bazhenova, Kelly Anne Shimabukuro, Barbara A. Parker, Paul Timothy Fanta, Razelle Kurzrock · 2015 · Cell Cycle
  60. Transferable scoring function based on semiempirical quantum mechanical PM6-DH2 method: CDK2 with 15 structurally diverse inhibitors
    Petr Dobeš, Jindřich Fanfrlík, Jan Řezáč, Michal Otyepka, Pavel Hobza · 2011 · Journal of Computer-Aided Molecular Design
  61. miR-25 promotes glioma cell proliferation by targeting CDKN1C
    Jihong Zhang, Xuhai Gong, Kaiyu Tian, Dongkai Chen, Jiahang Sun, Guangzhi Wang, Mian Guo · 2015 · Biomedicine & Pharmacotherapy
  62. Analysis of cyclins A, B1, D1 and E in breast cancer in relation to tumour grade and other prognostic factors
    Pia Boström, Mirva Söderström, Tuire Palokangas, Tero J. Vahlberg, Yrjö U. Collan, Olli Carpén, Pirkko Hirsimäki · 2009 · BMC Research Notes
  63. Phosphorylation of ORC2 Protein Dissociates Origin Recognition Complex from Chromatin and Replication Origins
    Kyung Yong Lee, Sung Woong Bang, Sang Wook Yoon, Seung‐Hoon Lee, Jong‐Bok Yoon, Deog Su Hwang · 2012 · Journal of Biological Chemistry
  64. Clinical study of the novel cyclin-dependent kinase inhibitor dinaciclib in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia patients
    Claire Fabre, Marco Gobbi, Cyrine Ezzili, Mustapha Zoubir, Marie‐Paule Sablin, Karen A. Small, Ellie Im, Nabeegha Shinwari, Da Zhang, Honghong Zhou et al. · 2014 · Cancer Chemotherapy and Pharmacology
  65. Expression of PRDX6 Correlates with Migration and Invasiveness of Colorectal Cancer Cells
    Wen‐Shih Huang, Cheng-Yi Huang, Meng‐Chiao Hsieh, Yi-Hung Kuo, Shui‐Yi Tung, Chien‐Heng Shen, Yung‐Yu Hsieh, Chih‐Chuan Teng, Ko‐Chao Lee, Kam-Fai Lee et al. · 2018 · Cellular Physiology and Biochemistry
  66. It takes a team: a gain-of-function story of p53-R249S
    Huai Wang, Peng Liao, Shelya X. Zeng, Hua Lu · 2019 · Journal of Molecular Cell Biology
  67. G Protein γ subunit 7 loss contributes to progression of clear cell renal cell carcinoma
    Shan Xu, Haibao Zhang, Tianjie Liu, Yule Chen, Dalin He, Lei Li · 2019 · Journal of Cellular Physiology
  68. Establishment and Characterization of 5-Fluorouracil-Resistant Human Colorectal Cancer Stem-Like Cells: Tumor Dynamics under Selection Pressure
    Maria Giovanna Francipane, Denis S. Bulanin, Eric Lagasse · 2019 · International Journal of Molecular Sciences
  69. CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in cell cycle may be a critical process in hepatocellular carcinoma
    Ling Li, Kang Huang, Huijia Zhao, Binyao Chen, Qifa Ye, Jiang Yue · 2020 · Cell Cycle
  70. Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasis
    Xuezhen Zeng, Jingying Zhou, Zhewen Xiong, Hanyong Sun, Weiqin Yang, Myth T.S. Mok, Jing Wang, Jingqing Li, Man Liu, Wenshu Tang et al. · 2020 · Cellular and Molecular Immunology
  71. Stearoyl-CoA desaturase 5 (SCD5), a Δ-9 fatty acyl desaturase in search of a function
    R. Ariel Igal, Debora I. Sinner · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  72. Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer
    Navid Sobhani, Anne Fassl, Giuseppina Mondani, Daniele Generali, Tobias Otto · 2021 · Cells
  73. PP2A mediates diosmin p53 activation to block HA22T cell proliferation and tumor growth in xenografted nude mice through PI3K–Akt–MDM2 signaling suppression
    Tran Duc Dung, Cecilia Hsuan Day, Truong Viet Binh, Cheng‐Chieh Lin, Hsi-Hsien Hsu, Cheng‐Chuan Su, Yueh-Min Lin, Fuu‐Jen Tsai, Wei‐Wen Kuo, Li-Mien Chen et al. · 2012 · Food and Chemical Toxicology
  74. Multilevel proteomic analyses reveal molecular diversity between diffuse-type and intestinal-type gastric cancer
    Shi, Wenhao, Wang, Yushen, Xu, Chen, Li, Yan, Ge, Sai, Bai, Bin, Zhang, Kecheng, Wang, Yunzhi, Zheng, Nairen, Wang, Juan et al. · 2023 · Nature Communications
  75. On the correlation between material-induced cell shape and phenotypical response of human mesenchymal stem cells
    Aliaksei S. Vasilevich, Steven Vermeulen, Marloes M. J. Kamphuis, Nadia J. T. Roumans, Kerbaï Saïd Eroumé, Dennie G.A.J. Hebels, Jeroen van de Peppel, Rika Reihs, Nick R. M. Beijer, Aurélie Carlier et al. · 2020 · Scientific Reports
  76. The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer
    Pingting Ye, Lei Feng, Shuo Shi, Chunyan Dong · 2022 · Cancers
  77. An Integrative Human Pan-Cancer Analysis of Cyclin-Dependent Kinase 1 (CDK1)
    Xuanyou Liu, Hao Wu, Zhenguo Liu · 2022 · Cancers
  78. Super-enhancers complexes zoom in transcription in cancer
    MengTing Wang, Qingyang Chen, ShuJie Wang, Han Xie, Jun Liu, Ruixiang Huang, Yufei Xiang, Yan‐Yi Jiang, Dasheng Tian, Erbao Bian · 2023 · Journal of Experimental & Clinical Cancer Research
  79. CDK4/6 inhibitors: basics, pros, and major cons in breast cancer treatment with specific regard to cardiotoxicity – a narrative review
    Dragica Pavlovic, Danijela Nićiforović, Dragana Papic, Katarina Milojevic, Marina Marković · 2023 · Therapeutic Advances in Medical Oncology
  80. Cellular and Molecular Mechanisms Modulated by Genistein in Cancer
    Valeria Naponelli, Annamaria Piscazzi, Domenica Mangieri · 2025 · International Journal of Molecular Sciences
  81. Translation initiation: a critical signalling node in cancer
    Francis Robert, Jerry Pelletier · 2009 · Expert Opinion on Therapeutic Targets
  82. S-adenosylmethionine limitation induces p38 mitogen activated protein kinase and triggers cell cycle arrest in G1
    Dawei Lin, Benjamin P. Chung, Peter Kaiser · 2013 · Journal of Cell Science
  83. Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 Suppression
    Chiun Hsu, Liang‐In Lin, Yu‐Che Cheng, Zi-Rui Feng, Yu‐Yun Shao, Ann‐Lii Cheng, Da‐Liang Ou · 2015 · Clinical Cancer Research
  84. miR-411 contributes the cell proliferation of lung cancer by targeting FOXO1
    Zhiju Zhao, Limei Qin, Shu Li · 2015 · Tumor Biology
  85. A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer
    Shu‐Fu Lin, Jen‐Der Lin, Chuen Hsueh, Ting‐Chao Chou, Richard J. Wong · 2017 · PLoS ONE
  86. Dietary compound proanthocyanidins from Chinese bayberry (Myrica rubra Sieb. et Zucc.) leaves inhibit angiogenesis and regulate cell cycle of cisplatin-resistant ovarian cancer cells via targeting Akt pathway
    Yu Zhang, Shiguo Chen, Chaoyang Wei, Gary O'Neal Rankin, Yon Rojanasakul, Ning Ren, Xingqian Ye, Yi Chen · 2017 · Journal of Functional Foods
  87. CDK8/19 inhibition induces premature G1/S transition and ATR-dependent cell death in prostate cancer cells
    Akito Nakamura, Daisuke Nakata, Yuichi Kakoi, Mihoko Kunitomo, Saomi Murai, Shunsuke Ebara, Akito Hata, Takahito Hara · 2018 · Oncotarget
  88. Ribociclib, a selective cyclin D kinase 4/6 inhibitor, inhibits proliferation and induces apoptosis of human cervical cancer in vitro and in vivo
    Yudi Xiong, Tianqi Li, Ganiou Assani, Huan Ling, Qian Zhou, Yangyang Zeng, Fuxiang Zhou, Yunfeng Zhou · 2019 · Biomedicine & Pharmacotherapy
  89. Molecular regulation of hematopoietic stem cell quiescence
    Zhe Chen, Qian Guo, Guanbin Song, Yu Hou · 2022 · Cellular and Molecular Life Sciences
  90. Total Synthesis and Biological Evaluation of Grassypeptolide A
    Hui Liu, Yuqing Liu, Zhuo Wang, Xiangyou Xing, Anita R. Maguire, Hendrik Luesch, Hui Zhang, Zhengshuang Xu, Tao Ye · 2013 · Chemistry - A European Journal
  91. Allyl isothiocyanate triggers G2/M phase arrest and apoptosis in human brain malignant glioma GBM 8401 cells through a mitochondria-dependent pathway
    Lin · 2010 · Oncology Reports
  92. Cell size homeostasis is maintained by CDK4-dependent activation of p38 MAPK
    Ceryl Tan, Miriam Bracha Ginzberg, Rachel Webster, Seshu Iyengar, Shixuan Liu, David J. Papadopoli, John B. Concannon, Yuan Wang, Douglas S. Auld, Jeremy L. Jenkins et al. · 2021 · Developmental Cell
  93. Nuclear dihydroxyacetone phosphate signals nutrient sufficiency and cell cycle phase to global histone acetylation
    Jiaojiao Zhang, Tingting Fan, Yun-Zi Mao, Jun‐Li Hou, Meng Wang, Min Zhang, Yan Lin, Lei Zhang, Guoquan Yan, Yanpeng An et al. · 2021 · Nature Metabolism
  94. Targeting CDK4/6 for Anticancer Therapy
    Jiating Qi, Zhuqing Ouyang · 2022 · Biomedicines
  95. An Activity-Based Oxaziridine Platform for Identifying and Developing Covalent Ligands for Functional Allosteric Methionine Sites: Redox-Dependent Inhibition of Cyclin-Dependent Kinase 4
    Angel Gonzalez-Valero, Audrey G. Reeves, Annika C. S. Page, Patrick J. Moon, Edward Miller, Katia Coulonval, Steven W. M. Crossley, Xiao Xie, Dan He, Patricia Zhang Musacchio et al. · 2022 · Journal of the American Chemical Society
  96. The circadian protein BMAL1 supports endothelial cell cycle during angiogenesis
    Matteo Astone, Roxana Elena Oberkersch, Giovanni Tosi, Alberto Biscontin, Massimo Mattia Santoro · 2023 · Cardiovascular Research
  97. NIRF/UHRF2 occupies a central position in the cell cycle network and allows coupling with the epigenetic landscape
    Tsutomu Mori, Daisuke D. Ikeda, Yoshiki Yamaguchi, Motoko Unoki · 2012 · FEBS Letters
  98. Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer
    Eliane C.M. Zeestraten, Matthias Maak, Masaki Shibayama, Tibor Schuster, Ulrich Nitsche, Tomoko Matsushima, Satoshi Nakayama, Keigo Gohda, Helmut Friess, Cornelis J.�H. van de Velde et al. · 2011 · British Journal of Cancer
  99. Mitochondrial oxidative stress elicits chromosomal instability after exposure to isocyanates in human kidney epithelial cells
    Pradyumna Kumar Mishra, Gorantla Venkata Raghuram, Hariom Panwar, Deepika Kumari Jain, Hemant Pandey, Kewal Krishan MAUDAR · 2009 · Free Radical Research
  100. Eriocalyxin B induces apoptosis and cell cycle arrest in pancreatic adenocarcinoma cells through caspase- and p53-dependent pathways
    Lin Li, Grace Gar‐Lee Yue, Clara Bik‐San Lau, Han‐Dong Sun, Kwok‐Pui Fung, Ping Chung Leung, Quan‐Bin Han, Po Sing Leung · 2012 · Toxicology and Applied Pharmacology